Brokerages expect that Davita Inc (NYSE:DVA) will report earnings per share (EPS) of $1.00 for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Davita’s earnings, with the lowest EPS estimate coming in at $0.93 and the highest estimate coming in at $1.16. Davita reported earnings per share of $1.05 in the same quarter last year, which would suggest a negative year-over-year growth rate of 4.8%. The business is expected to report its next quarterly earnings results on Thursday, May 2nd.
According to Zacks, analysts expect that Davita will report full year earnings of $4.42 per share for the current fiscal year, with EPS estimates ranging from $3.61 to $4.95. For the next year, analysts anticipate that the business will post earnings of $5.40 per share, with EPS estimates ranging from $4.59 to $6.88. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that that provide coverage for Davita.
Get Davita alerts:Davita (NYSE:DVA) last posted its quarterly earnings data on Wednesday, February 13th. The company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.89 by $0.01. The company had revenue of $2.82 billion during the quarter, compared to analyst estimates of $2.97 billion. Davita had a net margin of 1.40% and a return on equity of 13.75%. Davita’s quarterly revenue was up 1.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.92 earnings per share.
A number of analysts have recently issued reports on DVA shares. Zacks Investment Research raised shares of Davita from a “sell” rating to a “hold” rating in a research note on Thursday, February 14th. Robert W. Baird lowered their target price on shares of Davita from $90.00 to $70.00 and set an “outperform” rating for the company in a research note on Friday. They noted that the move was a valuation call. Raymond James lowered shares of Davita from an “outperform” rating to a “market perform” rating and set a $63.44 target price for the company. in a research note on Sunday, December 2nd. Royal Bank of Canada boosted their target price on shares of Davita from $70.00 to $78.00 and gave the company a “sector perform” rating in a research note on Thursday, November 8th. Finally, TheStreet lowered shares of Davita from a “b-” rating to a “c+” rating in a research note on Thursday, November 8th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $66.92.
Institutional investors and hedge funds have recently modified their holdings of the company. CSat Investment Advisory L.P. boosted its stake in shares of Davita by 61.8% during the fourth quarter. CSat Investment Advisory L.P. now owns 581 shares of the company’s stock valued at $30,000 after purchasing an additional 222 shares during the period. Quantamental Technologies LLC purchased a new stake in Davita in the fourth quarter worth about $34,000. Oregon Public Employees Retirement Fund lifted its stake in Davita by 4,995.1% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,880,451 shares of the company’s stock worth $37,000 after acquiring an additional 1,843,544 shares during the period. Fort L.P. purchased a new stake in Davita in the fourth quarter worth about $76,000. Finally, Dupont Capital Management Corp lifted its stake in Davita by 41.0% in the fourth quarter. Dupont Capital Management Corp now owns 2,525 shares of the company’s stock worth $130,000 after acquiring an additional 734 shares during the period. 85.99% of the stock is owned by hedge funds and other institutional investors.
NYSE DVA traded up $0.04 on Thursday, hitting $59.14. 1,722,104 shares of the stock were exchanged, compared to its average volume of 1,680,422. The company has a quick ratio of 1.82, a current ratio of 1.84 and a debt-to-equity ratio of 2.09. The firm has a market capitalization of $9.87 billion, a price-to-earnings ratio of 16.57, a PEG ratio of 0.59 and a beta of 1.31. Davita has a 52-week low of $48.25 and a 52-week high of $79.11.
About Davita
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Story: Why do earnings reports matter?
Get a free copy of the Zacks research report on Davita (DVA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment